Literature DB >> 29297421

Tuberculosis and diabetes in low and moderate tuberculosis incidence countries.

P-H Lee1, H Fu2, M-R Lee3, M Magee4, H-H Lin5.   

Abstract

In countries with low and moderate incidence of tuberculosis (TB), the disease tends to concentrate in specific high-risk populations such as people with diabetes mellitus (DM). We review the updated evidence on the association between 1) DM and active TB, and 2) DM and latent tuberculous infection (LTBI), and 3) we summarize the findings on the population-level impact of DM on TB epidemiology, with particular focus on low- and moderate-incidence settings. We conducted an updated review of studies on DM and active TB, and found 11 more cohort studies published after the previous systematic review from 2008. The updated pooled relative risk (RR) (2.03, 95%CI 1.62-2.55) of all the studies was substantially lower than the three-fold risk increase in the previous review. Substantial heterogeneity of RR across studies was found. Possible reasons for such heterogeneity include different levels of residual confounding, the effect of modification by age, and different levels of glycemic control in the population. In a recently published systematic review on DM and LTBI, one cohort study and 12 cross-sectional studies were identified. The results from cross-sectional studies suggest a significant but modestly increased risk of LTBI among patients with DM (pooled odds ratio 1.18, 95%CI 1.06-1.30). We reviewed evidence on the population-level impact of DM on TB epidemiology in studies using population-attributable fraction analysis and infectious disease modelling. Those studies revealed that DM accounted for a substantial TB burden in low- and moderate-incidence countries. Finally, we discussed the complex association of obesity, DM and TB risk and the impact of the global obesity pandemic on TB epidemiology.

Entities:  

Mesh:

Year:  2018        PMID: 29297421     DOI: 10.5588/ijtld.17.0329

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

Review 1.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

2.  Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection.

Authors:  Matthew J Magee; Anjali Khakharia; Neel R Gandhi; Cheryl L Day; Hardy Kornfeld; Mary K Rhee; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2022-04-01       Impact factor: 17.152

3.  Subjects With Diabetes Mellitus Are at Increased Risk for Developing Tuberculosis: A Cohort Study in an Inner-City District of Barcelona (Spain).

Authors:  Violeta Antonio-Arques; Josep Franch-Nadal; Antonio Moreno-Martinez; Jordi Real; Àngels Orcau; Didac Mauricio; Manel Mata-Cases; Josep Julve; Elena Navas Mendez; Rai Puig Treserra; Joan Barrot de la Puente; Joan Pau Millet; Jose Luis Del Val García; Bogdan Vlacho; Joan A Caylà
Journal:  Front Public Health       Date:  2022-05-23

4.  Association amid the comorbidity of Diabetes Mellitus in patients of Active Tuberculosis in Pakistan: A matched case control study.

Authors:  Nadia Khalid; Farah Ahmad; Farhan Muhammad Qureshi
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

5.  Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.

Authors:  Monica Sane Schepisi; Assunta Navarra; M Nieves Altet Gomez; Andrii Dudnyk; Anne Margarita Dyrhol-Riise; Jaime Esteban; Pier Francesco Giorgetti; Gina Gualano; Lorenzo Guglielmetti; Jan Heyckendorf; Anna Kaluzhenina; Berit Lange; Christoph Lange; Katerina Manika; Jalal Miah; Zorica Nanovic; Emanuele Pontali; Monica Rios Prego; Ivan Solovic; Simon Tiberi; Fabrizio Palmieri; Enrico Girardi
Journal:  Open Forum Infect Dis       Date:  2018-12-19       Impact factor: 3.835

6.  Impact of Diabetes Mellitus on the Presentation and Response to Treatment of Adults With Pulmonary Tuberculosis in Qatar.

Authors:  Khalid M Dousa; Abdelrahman Hamad; Mohamed Albirair; Hussam Al Soub; Abdel-Naser Elzouki; Mahmoud I Alwakeel; Bonnie A Thiel; John L Johnson
Journal:  Open Forum Infect Dis       Date:  2018-12-19       Impact factor: 3.835

Review 7.  Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia.

Authors:  Minh Dao Ngo; Stacey Bartlett; Katharina Ronacher
Journal:  Microorganisms       Date:  2021-11-02

8.  Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection.

Authors:  A Largen; A Ayala; R Khurana; D J Katz; T K Venkatappa; R Brostrom
Journal:  Int J Tuberc Lung Dis       Date:  2021-07-01       Impact factor: 3.427

9.  Tuberculosis treatment outcomes of notified cases: trends and determinants of potential unfavourable outcome, France, 2008 to 2014.

Authors:  Jean-Paul Guthmann; Lucie Léon; Delphine Antoine; Daniel Lévy-Bruhl
Journal:  Euro Surveill       Date:  2020-01

10.  Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia.

Authors:  Nor Zam Azihan Mohd Hassan; Asmah Razali; Mohd Ridzwan Shahari; Mohd Shaiful Jefri Mohd Nor Sham Kunusagaran; Juanita Halili; Nur Amalina Zaimi; Mohd Shahri Bahari; Farhana Aminuddin
Journal:  Front Public Health       Date:  2021-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.